---
title: "ACS updates prostate cancer guidance: routine biennial PSA screening for men 50–69"
id: "stat-news-1-american-cancer-society-revises-guidelines-urges-routine-psa-screening-for"
canonical_url: "https://medichelpline.com/clinical-feed/stat-news-1-american-cancer-society-revises-guidelines-urges-routine-psa-screening-for"
content_type: "clinical_feed_article"
specialty: "Oncology"
source_name: "STAT News"
source_url: "https://www.statnews.com/2026/11/12/prostate-cancer-screening-guidelines-updated-acs/?utm_campaign=rss"
published_at: "2026-11-12T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# ACS updates prostate cancer guidance: routine biennial PSA screening for men 50–69
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/stat-news-1-american-cancer-society-revises-guidelines-urges-routine-psa-screening-for
- **Specialty:** [Oncology](https://medichelpline.com/clinical-feed/oncology.md)
- **Primary Source:** STAT News
- **Source URL:** [Original Journal Publication](https://www.statnews.com/2026/11/12/prostate-cancer-screening-guidelines-updated-acs/?utm_campaign=rss)
- **Published At:** 2026-11-12T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The American Cancer Society now recommends routine **PSA** blood testing every two years for average-risk men aged 50–69, replacing the 2010 guidance that left testing to patient-physician discretion. - For men at higher risk — specifically **Black men** and those with a strong family history — the ACS advises annual **PSA** screening beginning at age 45. - The guidelines set a clarified threshold: a **PSA** level of 3.0 ng/mL or higher is considered elevated for men 45–69; many labs still report 4.0 ng/mL as normal, the ACS authors and outside urologists noted. - To reduce overdiagnosis and unnecessary biopsies, the ACS recommends two elevated **PSA** results followed by an MRI and/or additional biomarker testing prior to biopsy; MRI is preferred before biopsy if available. - Screening decisions past age 70 should be individualized; screening should stop at 80 or in men unlikely to live another 10 years, per the new guidance. - The ACS panel did not endorse a single secondary biomarker; authors said they plan further study to compare available tests. - The U.S. Preventive Services Task Force has not yet changed its recommendations and still favors individualized decision-making; it has announced an upcoming update. - Patient advocates and some clinicians welcomed the shift toward more routine screening and clearer follow-up steps, while authors emphasized active surveillance for detected low-risk cancers to avoid overtreatment. - The source did not report specific screening implementation logistics, cost estimates, or comparative outcome metrics beyond the cited reductions in disease-specific mortality from recent studies.
## Clinical Analysis & Structured Key Points
[Skip to Main Content](https://www.statnews.com/2026/11/12/prostate-cancer-screening-guidelines-updated-acs/?utm_campaign=rss#wrapper) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo-white.svg) ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/2026/11/12/prostate-cancer-screening-guidelines-updated-acs/?utm_campaign=rss) [FDA](https://www.statnews.com/topic/fda/) [Obesity](https://www.statnews.com/topic/obesity/) [research](https://www.statnews.com/topic/research/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) My Account * [Settings Complete your personal information for a more tailored experience ](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing](https://www.statnews.com/my-account/billing/) * [Log In](https://www.statnews.com/login/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) Reporting from the frontiers of health and medicine ](https://www.statnews.com/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Public Health](https://www.statnews.com/category/health/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Policy](https://www.statnews.com/category/politics/) * [Science](https://www.statnews.com/category/in-the-lab/) * [First Opinion](https://www.statnews.com/category/first-opinion/) * [STAT+](https://www.statnews.com/topic/stat-plus/) * [Midterms 2026](https://www.statnews.com/midterms-2026-health-care-policy-issues/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) Search * [Log In](https://www.statnews.com/login/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [My Account](https://www.statnews.com/my-account/) My Account * [Settings](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing History](https://www.statnews.com/my-account/billing/) [Home](https://www.statnews.com/) News * [Latest](https://www.statnews.com/latest/) * [Series & Investigations](https://www.statnews.com/stat-series-and-investigations-award-winning-journalism/) * Business * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Health Insurance](https://www.statnews.com/category/insurance/) * [Hospitals](https://www.statnews.com/category/hospitals/) * [Medical Devices](https://www.statnews.com/topic/medical-devices/) * Washington * [Policy](https://www.statnews.com/category/politics/) * [FDA](https://www.statnews.com/topic/fda/) * [NIH](https://www.statnews.com/topic/nih/) * Science * [CRISPR](https://www.statnews.com/topic/crispr/) * [Gene Therapy](https://www.statnews.com/topic/gene-therapy/) * [Neuroscience](https://www.statnews.com/topic/neuroscience/) * Public Health * [Addiction](https://www.statnews.com/topic/addiction/) * [Covid-19](https://www.statnews.com/topic/coronavirus/) * [Abortion](https://www.statnews.com/topic/abortion/) * [Health Disparities](https://www.statnews.com/topic/health-disparities/) * [Infectious Disease](https://www.statnews.com/topic/infectious-disease/) * [Mental Health](https://www.statnews.com/topic/mental-health/) * Disease * [Cancer](https://www.statnews.com/topic/cancer/) * [Cardiovascular Disease](https://www.statnews.com/topic/cardiovascular-disease/) * [Chronic Disease](https://www.statnews.com/topic/chronic-disease/) * [Diabetes](https://www.statnews.com/topic/diabetes/) * [Alzheimer's](https://www.statnews.com/topic/alzheimers/) * [Obesity](https://www.statnews.com/topic/obesity/) * Features * [Trust in Science](https://www.statnews.com/trust-in-science/) * [Health Care Costs](https://www.statnews.com/health-insurance-costs-out-of-pocket-out-of-reach-series/) * [The Deadliest Drug](https://www.statnews.com/alcohol-epidemic-hiding-plain-sight-deadliest-drug-series/) [Newsletters](https://www.statnews.com/signup/) [Opinion](https://www.statnews.com/category/first-opinion/) Columns * [Adam Feuerstein](https://www.statnews.com/category/adams-take/) * [Matthew Herper](https://www.statnews.com/category/matts-take/) * [Ed Silverman](https://www.statnews.com/category/pharmalot-view/) [Reports](https://reports.statnews.com/) [E-books](https://www.statnews.com/ebooks/) [Podcasts](https://www.statnews.com/podcasts/) [Tools & Trackers](https://www.statnews.com/trackers/) * [CRISPR Tracker](https://www.statnews.com/feature/crispr/tracker/) * [Breakthrough Device Tracker](https://www.statnews.com/feature/stat-plus/breakthrough-device-designation-fda-tracker/) * [Generative AI Tracker](https://www.statnews.com/feature/stat-plus/generative-ai-health-hospitals-tracker/) * [Obesity Drug Tracker](https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/) [Events](https://www.statnews.com/events/) * [Upcoming Events](https://www.statnews.com/events#upcoming-events) * [Summits](https://www.statnews.com/stat-summits/) [Community](https://www.statnews.com/community/) * [STAT Madness 2027](https://www.statnews.com/feature/stat-madness/apply/) [Video](https://youtube.com/@Statnews) [Advertise](https://www.statnews.com/advertise/) * [STAT Brand Studio](https://sbs.statnews.com/) What's the word? Test your knowledge with our new weekday mini crossword [ Start solving ](https://www.statnews.com/stat-mini-crossword/) [Health](https://www.statnews.com/category/health/) # American Cancer Society revises guidelines, urges routine PSA screening for prostate cancer ## In major shift, ACS recommends biennial blood tests for average-risk men ages 50-69 * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/2026/11/12/prostate-cancer-screening-guidelines-updated-acs/?utm_campaign=rss) ![](https://www.statnews.com/wp-content/uploads/2026/11/AdobeStock_1544077528-645x645.jpeg) Adobe ![](https://www.statnews.com/wp-content/uploads/2023/07/Annalisa-Merelli-avatar-round-80x80.png) By [Annalisa Merelli](https://www.statnews.com/staff/annalisa-merelli/) Nov. 12, 2026 Contributing Writer ![](https://www.statnews.com/wp-content/uploads/2023/07/Annalisa-Merelli-avatar-round-80x80.png) [Annalisa Merelli](https://www.statnews.com/staff/annalisa-merelli/) 1. [](https://x.com/missanabeem "X") Annalisa.Merelli@statnews.com Annalisa (Nalis) Merelli is focused on boys’ and men’s health: She looks into reproductive health, trending treatments, screening approaches, mental health, and everything in between. [Get email alerts for Annalisa MerelliSigned up for email alertsRemove email alerts](https://www.statnews.com/2026/11/12/prostate-cancer-screening-guidelines-updated-acs/?utm_campaign=rss) [Subscribe](https://www.statnews.com/stat-plus/) or [log in](https://www.statnews.com/login/) to STAT+ to unlock email alerts In a major change to screening guidelines, the [American Cancer Society recommended](https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.70112) on Thursday that American men between ages 50 and 69 at an average risk of prostate cancer should test their prostate-specific antigen (PSA) blood levels every two years. The prior guidelines, released in 2010, left testing for average-risk men to their discretion, [after assessing cancer risk](https://www.cancer.org/cancer/types/prostate-cancer/detection-diagnosis-staging/acs-recommendations.html) with a physician. Advertisement Related Story ![](https://www.statnews.com/wp-content/uploads/2026/05/AdobeStock_111509515-768x432.jpeg) ### [PSA screening for prostate cancer reduces disease-specific deaths, new review shows](https://www.statnews.com/2026/05/14/psa-tests-reduce-risk-prostate-cancer-deaths-new-study-cochrane-review/) Similarly, PSA testing recommendations were strengthened for high risk groups — Black men and men with a strong family history of prostate cancer. They are now encouraged to get PSA-based screening yearly starting at 45. Black men in particular disproportionately die from prostate cancer, and the guideline authors said they hope that increased surveillance will reduce the number of Black patients presenting with cancers at advanced stages. [Cancer](https://www.statnews.com/topic/cancer/), [Health Disparities](https://www.statnews.com/topic/health-disparities/), [public health](https://www.statnews.com/topic/public-health/) [Submit a correction request](https://www.statnews.com/contact/?how_can_we_help_=Editorial%20Correction%20Request)[Reprints](https://www.parsintl.com/publications/stat/) 1. ![](https://www.statnews.com/wp-content/uploads/2023/07/Annalisa-Merelli-avatar-round-80x80.png) [Annalisa Merelli](https://www.statnews.com/staff/annalisa-merelli/) 1. [](https://x.com/missanabeem "X") 2. Contributing Writer 1. [](https://x.com/missanabeem "X") 2. Annalisa (Nalis) Merelli is focused on boys’ and men’s health: She looks into reproductive health, trending treatments, screening approaches, mental health, and everything in between. ![](https://www.statnews.com/wp-content/themes/stat/images/article-new/envelope-open.svg) ![](https://www.statnews.com/wp-content/uploads/2023/06/Cancer-Briefing-Logo-Black-640x442.png) ### Newsletter Critical updates on the fast-moving world of cancer research, treatment, and patient care Please enter a valid email address. Sign Up Your data will be processed in accordance with our [Privacy Policy](https://www.statnews.com/privacy/) and [Terms of Service](https://www.statnews.com/terms-conditions/). You may opt out of receiving STAT communications at any time. Advertisement Most Popular 1. ![](https://www.statnews.com/wp-content/uploads/2019/09/AP_060324030695-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [FDA approves novel Bayer drug to reduce recurrence of stroke](https://www.statnews.com/2026/11/09/cardiovascular-stroke-recurrence-bayer-drug-fda-approval/) 2. ![](https://www.statnews.com/wp-content/uploads/2018/08/AP_18056287644136-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Alnylam, once in the hunt to be a $100 billion biotech, needs to solve its heart drug problem ](https://www.statnews.com/2026/11/12/alnylam-amvuttra-heart-drug-growth/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/10/AdobeStock_391451620_Editorial_Use_Only-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Former Eli Lilly rep claims she was fired for complaining about marketing of Mounjaro diabetes drug](https://www.statnews.com/pharmalot/2026/11/10/former-lilly-rep-claims-she-was-fired-for-complaining-about-marketing-of-mounjaro-diabetes-drug/) 4. ![](https://www.statnews.com/wp-content/uploads/2018/10/STAT_Biogen01-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [What to know about Biogen’s big lupus study readout](https://www.statnews.com/2026/11/12/biogen-lupus-litifilimab-what-to-know/) 5. ![](https://www.statnews.com/wp-content/uploads/2026/09/AP26267649095665-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Cassidy sets key vote on Overton, even as he remains undecided on nominee to lead FDA](https://www.statnews.com/2026/11/11/fda-commissioner-nominee-heidi-overton-senate-committee-vote/) #### [ Reports ](https://reports.statnews.com/) [ ![](https://www.statnews.com/wp-content/uploads/2026/08/2026_CancerReport_ReportCover-328x424.jpg) Explore Cancer’s transformational moments: KRAS, CAR-T, immunotherapy, and more ](https://reports.statnews.com/products/cancer-transformational-moments-advances-in-kras-car-t-immunotherapy) Advertisement #### [Events](https://www.statnews.com/events/) [ ![](https://www.statnews.com/wp-content/uploads/2026/10/STATatHLTH_Wordpress_CalendarImage-80x80.jpg) STAT@hlth. A Dose of Reality on EHRs and AI In-person Nov 18 ](https://www.statnews.com/event/stathlth-a-dose-of-reality-on-ehrs-and-ai/) [ ![](https://www.statnews.com/wp-content/uploads/2026/09/2026ASH_Wordpress_CalendarImage-80x80.jpg) STAT@ASH: Medicine’s Bleeding Edge New Orleans, LA Dec 13 ](https://www.statnews.com/event/stat-at-ash-meeting-2026/) [ ![](https://www.statnews.com/wp-content/uploads/2026/09/BTE2027_Wordpress_CalendarImage-80x80.jpg) 2027 Breakthrough Summit East New York City, NY Mar 18 ](https://www.statnews.com/event/2027-stat-breakthrough-summit-east/) Most Read in [STAT+](https://www.statnews.com/stat-plus/) 1. ![](https://www.statnews.com/wp-content/uploads/2026/11/AdobeStock_6400491-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [FDA warns GLP-1 drugs carry potential risk of rare eye condition](https://www.statnews.com/2026/11/09/glp-1-drugs-potential-risk-rare-eye-condition-naion-fda/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/11/AdobeStock_1874804219-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Beyond statins, one drug lowered heart attack risk by 20%](https://www.statnews.com/2026/11/05/repatha-vs-zetia-cholesterol-study-heart-attack-risk/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/10/AdobeStock_391451620_Editorial_Use_Only-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Former Eli Lilly rep claims she was fired for complaining about marketing of Mounjaro diabetes drug](https://www.statnews.com/pharmalot/2026/11/10/former-lilly-rep-claims-she-was-fired-for-complaining-about-marketing-of-mounjaro-diabetes-drug/) 4. ![](https://www.statnews.com/wp-content/uploads/2021/05/ks051621_SMA_31-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Novartis cites cases of previously unknown tumors possibly tied to its SMA gene therapy](https://www.statnews.com/pharmalot/2026/11/05/novartis-sma-zolgensma-tumor-case-reports/) 5. ![](https://www.statnews.com/wp-content/uploads/2019/09/AP_060324030695-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [FDA approves novel Bayer drug to reduce recurrence of stroke](https://www.statnews.com/2026/11/09/cardiovascular-stroke-recurrence-bayer-drug-fda-approval/) #### Recommended ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Adam's Biotech Scorecard Adam's Biotech Scorecard November 12, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Alnylam, once in the hunt to be a $100 billion biotech, needs to solve its heart drug problem ](https://www.statnews.com/2026/11/12/alnylam-amvuttra-heart-drug-growth/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Adam's Biotech Scorecard Adam's Biotech Scorecard November 12, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: What to know about Biogen’s big lupus study readout ](https://www.statnews.com/2026/11/12/biogen-lupus-litifilimab-what-to-know/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) Advertisement ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) First Opinion First Opinion November 12, 2026 ### [ 3 things new governors must do to lead on health ](https://www.statnews.com/2026/11/12/new-governors-2027-health-priorities-agenda/) By Mandy Cohen and Ellen Montz ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) First Opinion First Opinion November 12, 2026 ### [ I research MAHA and Black Americans. The relationship is complicated — and fascinating ](https://www.statnews.com/2026/11/12/maha-black-american-activists-voters-health-care-midterms/) By Jerel Ezell ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Trust in Science Trust in Science November 12, 2026 ### [ Newly elected doctors and scientists hope to restore trust in science. It won’t be easy ](https://www.statnews.com/2026/11/12/trust-in-science-physician-lawmakers-rebuild-belief/) By [Nicholas Florko](https://www.statnews.com/staff/nicholas-florko/) #### Subscriber Picks 1. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Failure of Novartis Lp(a) drug raises questions about cardiovascular strategy ](https://www.statnews.com/2026/11/07/aha-conference-news-novartis-lp-a-pelacarsen-heart-disease-trial-mystery/) By [Elizabeth Cooney](https://www.statnews.com/staff/elizabeth-cooney/) and [Matthew Herper](https://www.statnews.com/staff/matthew-herper/) 2. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Why the latest heart drug failures should make us all more skeptical of AI hype ](https://www.statnews.com/2026/11/08/heart-drug-failures-lessons-for-artificial-intelligence-from-aha-conference/) By [Matthew Herper](https://www.statnews.com/staff/matthew-herper/) 3. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Novartis cites cases of previously unknown tumors possibly tied to its SMA gene therapy ](https://www.statnews.com/pharmalot/2026/11/05/novartis-sma-zolgensma-tumor-case-reports/) By [Ed Silverman](https://www.statnews.com/staff/ed-silverman/) and [Jason Mast](https://www.statnews.com/staff/jason-mast/) 4. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: The biotech startups skipping AI for drug discovery ](https://www.statnews.com/2026/11/04/the-biotech-startups-skipping-ai-for-drug-discovery-ai-prognosis/) By [Brittany Trang](https://www.statnews.com/staff/brittany-trang/) 5. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: CVS’ split doesn’t fix its fundamental problem ](https://www.statnews.com/2026/11/09/cvs-health-split-pbm-conflict-examined-anthony-loiacono-judi-health/) By A.J. Loiacono Share options * [ X ](https://twitter.com/intent/tweet?url=https://www.statnews.com/2026/11/12/prostate-cancer-screening-guidelines-updated-acs/&via=statnews&text=American%20Cancer%20Society%20revises%20guidelines%2C%20urges%20routine%20PSA%20screening%20for%20prostate%20cancer "Share on X") * [ Bluesky ](https://bsky.app/intent/compose?text=American%20Cancer%20Society%20revises%20guidelines%2C%20urges%20routine%20PSA%20screening%20for%20prostate%20cancer%20https://www.statnews.com/2026/11/12/prostate-cancer-screening-guidelines-updated-acs/%20via%20@statnews.com "Share on Bluesky") * [ LinkedIn ](https://www.linkedin.com/shareArticle?url=https://www.statnews.com/2026/11/12/prostate-cancer-screening-guidelines-updated-acs/&mini=true&source=STAT "Linkedin") * [ Facebook ](https://www
## Related Clinical Research

- [American Cancer Society now recommends biennial PSA screening for men 50–69](https://medichelpline.com/clinical-feed/stat-news-0-experts-update-prostate-cancer-screening-guidelines-for-men.md)
- [Democrats coalesce on 'Medicare for More' as health headlines shift](https://medichelpline.com/clinical-feed/stat-news-3-democrats-settle-on-a-message-medicare-for-more.md)
- [U.S. POINTER: Structured lifestyle program slows brain aging and cardiometabolic risk over 24 mont](https://medichelpline.com/clinical-feed/medical-news-today-0-combining-physical-mental-and-social-habits-slows-brain-aging-in-2-year-trial.md)
- [Ultra-processed foods linked to MRI signs of vascular brain injury in middle-aged adults](https://medichelpline.com/clinical-feed/medical-news-today-0-ultra-processed-foods-may-be-harming-brain-health-in-otherwise-healthy-adults.md)

## Navigation
- [← Back to Oncology Feed](https://medichelpline.com/clinical-feed/oncology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.